Legacy Financial Group (Oklahoma)’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,700
Closed -$236K 74
2024
Q1
$236K Sell
1,700
-14
-0.8% -$1.76K 0.09% 64
2023
Q4
$213K Buy
+1,714
New +$175K 0.09% 67
2023
Q3
Sell
-1,739
Closed -$223K 72
2023
Q2
$223K Sell
1,739
-25
-1% -$3.02K 0.11% 67
2023
Q1
$205K Sell
1,764
-71
-4% -$7.95K 0.11% 62
2022
Q4
$208K Buy
+1,835
New +$201K 0.13% 60

Other funds holding DXCM

Legacy Financial Group (Oklahoma)'s DXCM Position: Q2 2024 in Review

Legacy Financial Group (Oklahoma) sold out of DexCom (DXCM) in Q2 2024, closing a stake of 1,700 shares — an estimated $236K sold.

Legacy Financial Group (Oklahoma) first reported a position in DXCM in Q4 2022 and held it in 5 quarters. The position peaked at $236K in Q1 2024. 999 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.

  • Legacy Financial Group (Oklahoma) reported no remaining DexCom position as of Q2 2024 after selling out during the quarter.
  • Legacy Financial Group (Oklahoma) sold 1,700 DexCom shares in Q2 2024, an estimated $236K.
  • Legacy Financial Group (Oklahoma) first reported a position in DexCom in Q4 2022 and held it in 5 quarters.
  • Legacy Financial Group (Oklahoma)'s DexCom position peaked at $236K in Q1 2024.
  • 999 funds tracked by Wall St. Rank held DexCom as of Q2 2024.

Based on Legacy Financial Group (Oklahoma)'s 13F filing for Q2 2024, filed 12 Aug 2024.